CHANTILLY, VIRGINIA / ACCESS Newswire / April 25, 2025 / Cipher Surgical, a leading innovator in laparoscopic surgical technology, today announced the successful completion of a $10 million Series A ...
Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced it has strengthened its product pipeline by acquiring the worldwide rights to three products from Astion ...
NEW YORK, NY / ACCESSWIRE / February 14, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market ...
MISSISSAUGA, ON, June 6, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that pharmaceutical industry medical executive, Dr. Diane Gajewczyk, has joined ...
MISSISSAUGA, ON, Jan. 19, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced the appointment of Lynne Bulger as Vice President, Medical ...
CHANTILLY, VA / ACCESSWIRE / March 4, 2024 / Cipher Surgical, a leading innovator in medical device technology, is pleased to announce a strategic leadership transition effective March 4, 2024. Mark ...
Cipher Surgical Completes $10 Million Series A Funding Round Led by MSI to Drive Global Expansion and Innovation in Surgical Visualization CHANTILLY, VIRGINIA / ACCESS Newswire / April 25, 2025 / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results